125 related articles for article (PubMed ID: 335659)
1. [Use of the genetic recombination method for obtaining vaccinal strains of the influenza virus].
Aleksandrova GI
Vopr Virusol; 1977; (4):387-95. PubMed ID: 335659
[No Abstract] [Full Text] [Related]
2. [Results and prospects for vaccinal prevention of influenza].
Smorodintsev AA; Aleksandrova GI
Vopr Virusol; 1977; (3):259-71. PubMed ID: 333765
[No Abstract] [Full Text] [Related]
3. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
Garmashova LM; Polezhaev FI; Aleksandrova GI
Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
[TBL] [Abstract][Full Text] [Related]
4. [The selection of cold-adapted variants of the influenza viruses H1N1 and H3N2 and their antigenic and genetic characteristics].
Podcherniaeva RIa; Döhner L; Medvedeva TE; Aleksandrova GI
Vopr Virusol; 1991; 36(2):100-2. PubMed ID: 1882517
[TBL] [Abstract][Full Text] [Related]
5. [Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children].
Gendon IuZ; Klimov AI; Lisovskaia KV; Aleksandrova GI; Medvedeva TI
Vopr Virusol; 1984; 29(1):22-8. PubMed ID: 6710977
[TBL] [Abstract][Full Text] [Related]
6. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus.
Massicot JG; Murphy BR; van Wyke K; Huang KY; Chanock RM
Virology; 1980 Oct; 106(1):187-90. PubMed ID: 6893373
[No Abstract] [Full Text] [Related]
7. [Experience in selecting safe heat-sensitive influenza virus A recombinants].
Aleksandrova GI; Garmashova LM; Golubev DB; Koliak LI; Medvedeva TE
Vopr Virusol; 1979; (4):342-6. PubMed ID: 483771
[TBL] [Abstract][Full Text] [Related]
8. [Genetic bases of the apathogenicity of live cold-adapted influenza vaccines].
Klimov AI; Medvedeva TE; Lisovskaia KV; Egorov AIu; Gendon IuZ
Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):48-52. PubMed ID: 3072808
[No Abstract] [Full Text] [Related]
9. [Biological and physicochemical principles of producing killed influenza vaccines].
Fridman EA; Kolikov VM; Peradze TV
Tr Inst Im Pastera; 1976; 47():7-13. PubMed ID: 1052953
[No Abstract] [Full Text] [Related]
10. [Live influenza vaccine].
Smorodintsev AA
Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
[No Abstract] [Full Text] [Related]
11. [Effectiveness of live influenza vaccines obtained by strain recombination and passages].
Zhilova GP; Orlov VA; Malikova EV; Kozhukhov VM
Vopr Virusol; 1987; 32(6):675-81. PubMed ID: 3445585
[TBL] [Abstract][Full Text] [Related]
12. Conditions for production of thermosensitive attenuated influenza virus recombinants.
Polezhaev FI; Garmashova LM; Polyakov YM; Golubev DB; Aleksandrova GI
Acta Virol; 1978 Jul; 22(4):263-9. PubMed ID: 29464
[TBL] [Abstract][Full Text] [Related]
13. [Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)].
Medvedeva TE; Kudriavtseva VK; Zhikhareva IV; Romashkina VV; Aleksandrova GI; Klimov AI
Vopr Virusol; 1991; 36(2):96-100. PubMed ID: 1882532
[TBL] [Abstract][Full Text] [Related]
14. A placebo-controlled dose-response study of the reactogenicity and immunogenicity of a cold-adapted recombinant A/Victoria/3/75 (H3N2) live influenza virus candidate vaccine in healthy volunteers.
Hrabar A; Vodopija I; André FE; Mitchell JR; Maassab HF; Hennessy AV; Davenport FM
Dev Biol Stand; 1977 Jun 1-3; 39():53-60. PubMed ID: 342317
[No Abstract] [Full Text] [Related]
15. [Characteristics of influenza virus depending on temperature of replication].
Brydak L
Med Dosw Mikrobiol; 1979; 31(4):245-50. PubMed ID: 544982
[No Abstract] [Full Text] [Related]
16. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
Lu B; Zhou H; Ye D; Kemble G; Jin H
J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
[TBL] [Abstract][Full Text] [Related]
17. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
[No Abstract] [Full Text] [Related]
18. [Selection of the influenza virus vaccinal strain by means of crossed protection experiments on mice].
Briantseva EA
Tr Inst Im Pastera; 1976; 47():19-23. PubMed ID: 1088724
[No Abstract] [Full Text] [Related]
19. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
20. [Immunogenic study of killed influenza vaccine purified and concentrated by a chromatographic method on silica sorbents. II. The immunogenic properties of a vaccine from the A/Scotland/74 strain].
Polzik TP; Bichurina MA; Goriunova VV; Bokhnevich GM; Polianskaia NIu
Tr Inst Im Pastera; 1976; 47():128-33. PubMed ID: 210538
[No Abstract] [Full Text] [Related]
[Next] [New Search]
